Developer docs
API playgroundTry for free, no card

Search company profiles

OmniSonics Medical Technologies

Full company profile

uuid0009rax

Namestring
OmniSonics Medical Technologies
Websiteurl
omnisonics.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

OmniSonics Medical Technologies was a U.S.-based medical device company founded in 1998 and headquartered in Lakewood, United States. Per firmographic data, the company developed medical devices used in the treatment of vascular occlusive diseases, an end-market suggesting catheter-based or ultrasound-based thrombectomy technology for clot removal in peripheral or deep venous applications.

The company operated as a private, venture-backed entity with 51-100 employees. Across four documented funding rounds between 2000 and 2007, OmniSonics raised approximately $89.7M in aggregate from a syndicate of notable medical device investors, including Canaan Partners, Domain Associates, General Electric Pension Trust, Hambrecht & Quist Capital Management, Johnson & Johnson Development Corporation, Mitsubishi International Corporation, New England Partners, Nomura International, and Prism Venture Management. The largest single round was a $43M Series 3 in October 2003, co-led by GE Pension Trust and Nomura International, indicating significant institutional confidence at the company's mid-stage. The most recent documented capital raise was a $20M round in July 2007.

The company's current operating status is uncertain. The primary domain, OmniSonics.com, is listed for sale on HugeDomains at $9,795, with the available source material limited to this domain listing page. No current product information, management team, revenue, customer base, or regulatory filings are documented in the input data, representing a significant evidence gap for any current operational assessment.

Short descriptiontext

OmniSonics Medical Technologies is a U.S.-based medical device company founded in 1998 that developed devices for treating vascular occlusive diseases. The private, venture-backed firm historically operated from Lakewood with 51-100 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLakewood, United States
HQ citystring
Lakewood
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical device manufacturing, vascular occlusive treatment, ultrasonic catheter technology, endovascular intervention devices, thrombectomy medical devices
Industry2 codes
PRIMARYHLAHAFAJ
Thrombectomy, Embolic Protection & Stroke Intervention Devices
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Vascular Medical Devices
Social media profiles1 record
Cost components5 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

OmniSonics Medical Technologies develops and manufactures medical devices used in the treatment of vascular occlusive diseases. The company focuses on an ultrasound-based catheter technology platform designed to address blocked or occluded blood vessels. Its offerings are intended for healthcare providers, including hospitals and vascular intervention specialists.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Ultrasonic vascular occlusion treatment devices
CategoryVascular intervention medical devices
Description

Medical devices that use ultrasound-based catheter technology to treat vascular occlusive diseases, intended for use by vascular surgeons and interventional specialists in hospital settings.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Penumbra is a leading developer of thrombectomy and aspiration systems for venous, arterial, and neurovascular occlusions. It is the most directly comparable peer, addressing the same vascular occlusive disease indications that OmniSonics targeted.

TypeDirect peer
Description

Inari Medical develops catheter-based thrombectomy devices (FlowTriever, ClotTriever) for venous thromboembolism and peripheral applications. It competes directly in the same vascular occlusion treatment category as OmniSonics' historical focus.

TypeBroad incumbent
Description

Stryker's Neurovascular business (built largely around the former Concentric Medical acquisition) offers stent retrievers and aspiration devices for stroke intervention. It is a broad incumbent with overlapping thrombectomy capabilities for vascular occlusion.

TypeBroad incumbent
Description

Medtronic operates a broad vascular and neurovascular portfolio including thrombectomy and embolic protection devices. As a diversified incumbent, it competes in the same disease space as OmniSonics but across many other categories as well.

TypeBroad incumbent
Description

Boston Scientific's peripheral interventions and neurology franchises include vascular access, thrombectomy, and embolic protection products. It is a broad incumbent with overlapping vascular occlusion device capabilities.

TypeDirect peer
Description

AngioDynamics develops and markets peripheral vascular devices including thrombectomy catheters (e.g., AngioVac). It is a direct peer in the vascular occlusive disease treatment market, though typically smaller scale than top-tier peers.

TypeBroad incumbent
Description

Teleflex offers vascular access and interventional products used in similar procedural contexts as OmniSonics' devices. It is a broader incumbent operating across multiple vascular and surgical device categories.

TypeBroad incumbent
Description

Abbott's vascular franchise includes devices for peripheral and coronary intervention, including embolic protection. As a diversified medical device incumbent, it competes in adjacent vascular occlusion applications.

9Terumo (Interventional Systems)
TypeBroad incumbent
Description

Terumo's interventional systems business includes guidewires, catheters, and access devices used in vascular occlusion procedures. It is a broad incumbent with overlapping procedural product lines.

TypeEmerging player
Description

Surmodics develops drug-coated balloon and thrombectomy technologies for peripheral vascular disease. It is an emerging player with meaningful but narrower overlap to OmniSonics' historical vascular occlusion focus.

Market position
Strengths2 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OmniSonics Medical Technologies

Vascular Medical Devicesomnisonics.com

OmniSonics Medical Technologies is a U.S.-based medical device company founded in 1998 that developed devices for treating vascular occlusive diseases. The private, venture-backed firm historically operated from Lakewood with 51-100 employees.

What OmniSonics Medical Technologies does

OmniSonics Medical Technologies was a U.S.-based medical device company founded in 1998 and headquartered in Lakewood, United States. Per firmographic data, the company developed medical devices used in the treatment of vascular occlusive diseases, an end-market suggesting catheter-based or ultrasound-based thrombectomy technology for clot removal in peripheral or deep venous applications.

The company operated as a private, venture-backed entity with 51-100 employees. Across four documented funding rounds between 2000 and 2007, OmniSonics raised approximately $89.7M in aggregate from a syndicate of notable medical device investors, including Canaan Partners, Domain Associates, General Electric Pension Trust, Hambrecht & Quist Capital Management, Johnson & Johnson Development Corporation, Mitsubishi International Corporation, New England Partners, Nomura International, and Prism Venture Management. The largest single round was a $43M Series 3 in October 2003, co-led by GE Pension Trust and Nomura International, indicating significant institutional confidence at the company's mid-stage. The most recent documented capital raise was a $20M round in July 2007.

The company's current operating status is uncertain. The primary domain, OmniSonics.com, is listed for sale on HugeDomains at $9,795, with the available source material limited to this domain listing page. No current product information, management team, revenue, customer base, or regulatory filings are documented in the input data, representing a significant evidence gap for any current operational assessment.

OmniSonics Medical Technologies firmographics

Firmographics
Name
OmniSonics Medical Technologies
Website
https://omnisonics.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
51–100 employees
Short description
OmniSonics Medical Technologies is a U.S.-based medical device company founded in 1998 that developed devices for treating vascular occlusive diseases. The private, venture-backed firm historically operated from Lakewood with 51-100 employees.
Ownership category
akta.pro rank

OmniSonics Medical Technologies industry classification

Industry
Product category
Vascular Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAJ
Thrombectomy, Embolic Protection & Stroke Intervention Devices
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAFAK
Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Medical device manufacturing
  • Vascular occlusive treatment
  • Ultrasonic catheter technology
  • Endovascular intervention devices
  • Thrombectomy medical devices

Where OmniSonics Medical Technologies is headquartered

Location

Headquarters

HQ city
Lakewood
HQ country
United States
HQ region
North America

Markets served

OmniSonics Medical Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

OmniSonics Medical Technologies product offering

Product offering

Core offering

OmniSonics Medical Technologies develops and manufactures medical devices used in the treatment of vascular occlusive diseases. The company focuses on an ultrasound-based catheter technology platform designed to address blocked or occluded blood vessels. Its offerings are intended for healthcare providers, including hospitals and vascular intervention specialists.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ultrasonic vascular occlusion treatment devices Medical devices that use ultrasound-based catheter technology to treat vascular occlusive diseases, intended for use by vascular surgeons and interventional specialists in hospital settings.

Companies that use OmniSonics Medical Technologies

Customer profile

Ideal customer profiles1 record

OmniSonics Medical Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

OmniSonics Medical Technologies partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights2 records

OmniSonics Medical Technologies competitors and assessment

Company assessment

Direct peers

  • Penumbra Inc. Penumbra is a leading developer of thrombectomy and aspiration systems for venous, arterial, and neurovascular occlusions. It is the most directly comparable peer, addressing the same vascular occlusive disease indications that OmniSonics targeted.
  • Inari Medical: Inari Medical develops catheter-based thrombectomy devices (FlowTriever, ClotTriever) for venous thromboembolism and peripheral applications. It competes directly in the same vascular occlusion treatment category as OmniSonics' historical focus.
  • AngioDynamics: AngioDynamics develops and markets peripheral vascular devices including thrombectomy catheters (e.g., AngioVac). It is a direct peer in the vascular occlusive disease treatment market, though typically smaller scale than top-tier peers.

Broad incumbents

  • Stryker (Neurovascular): Stryker's Neurovascular business (built largely around the former Concentric Medical acquisition) offers stent retrievers and aspiration devices for stroke intervention. It is a broad incumbent with overlapping thrombectomy capabilities for vascular occlusion.
  • Medtronic: Medtronic operates a broad vascular and neurovascular portfolio including thrombectomy and embolic protection devices. As a diversified incumbent, it competes in the same disease space as OmniSonics but across many other categories as well.
  • Boston Scientific: Boston Scientific's peripheral interventions and neurology franchises include vascular access, thrombectomy, and embolic protection products. It is a broad incumbent with overlapping vascular occlusion device capabilities.
  • Teleflex: Teleflex offers vascular access and interventional products used in similar procedural contexts as OmniSonics' devices. It is a broader incumbent operating across multiple vascular and surgical device categories.
  • Abbott (Vascular): Abbott's vascular franchise includes devices for peripheral and coronary intervention, including embolic protection. As a diversified medical device incumbent, it competes in adjacent vascular occlusion applications.
  • Terumo (Interventional Systems): Terumo's interventional systems business includes guidewires, catheters, and access devices used in vascular occlusion procedures. It is a broad incumbent with overlapping procedural product lines.

Emerging players

  • Surmodics: Surmodics develops drug-coated balloon and thrombectomy technologies for peripheral vascular disease. It is an emerging player with meaningful but narrower overlap to OmniSonics' historical vascular occlusion focus.

Market position

Strengths2 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

OmniSonics Medical Technologies social profiles

Digital presence

OmniSonics Medical Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OmniSonics Medical Technologies leadership team

Management profile

Number of profiles

OmniSonics Medical Technologies funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OmniSonics Medical Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OmniSonics Medical Technologies

What does OmniSonics Medical Technologies do?

OmniSonics Medical Technologies develops and manufactures medical devices used in the treatment of vascular occlusive diseases. The company focuses on an ultrasound-based catheter technology platform designed to address blocked or occluded blood vessels. Its offerings are intended for healthcare providers, including hospitals and vascular intervention specialists.

When was OmniSonics Medical Technologies founded?

OmniSonics Medical Technologies was founded in 1998. It employs 51 to 100 people.

Where is OmniSonics Medical Technologies based?

OmniSonics Medical Technologies is headquartered in Lakewood, United States, in the North America region.

Who are OmniSonics Medical Technologies's main competitors?

Direct peers on record are Penumbra Inc., Inari Medical and AngioDynamics. Broad incumbents are Stryker (Neurovascular), Medtronic, Boston Scientific, Teleflex, Abbott (Vascular) and Terumo (Interventional Systems). Surmodics is listed as an emerging player.

Does OmniSonics Medical Technologies have an API?

No public API is recorded for OmniSonics Medical Technologies.

What industry is OmniSonics Medical Technologies in?

OmniSonics Medical Technologies's product category is Vascular Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices, with a secondary code of HLAHAFAK, Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales